STOCK TITAN
  1. Home
  2. Sec-filings
  3. STE
  4. [Form 4] STERIS plc Insider Trading Activity

STERIS (NYSE: STE) SVP receives share awards and options grant

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STERIS plc SVP & Chief HRO Mary Clare Fraser reported routine equity compensation and related tax withholding. She received 3,009 ordinary shares at no cost and a grant of 10,492 employee stock options exercisable at $230.74 per share, expiring on June 2, 2036. As part of 2,028 restricted shares that vested on June 2, 2026, 591 shares valued at $209.76 per share were withheld to cover taxes. Following these transactions, she holds 15,218 ordinary shares directly, of which 7,554 remain restricted with scheduled lapses through June 4, 2029.

Positive

  • None.

Negative

  • None.
Insider Fraser Mary Clare
Role SVP & Chief HRO
Type Security Shares Price Value
Grant/Award Employee Stock Option (right to buy) 10,492 $0.00 --
Grant/Award Ordinary Shares 3,009 $0.00 --
Tax Withholding Ordinary Shares 591 $209.76 $124K
Holdings After Transaction: Employee Stock Option (right to buy) — 10,492 shares (Direct, null); Ordinary Shares — 15,218 shares (Direct, null)
Footnotes (1)
  1. As of June 2, 2026, 7,554 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 835 on June 3, 2026; 1,360 on June 4, 2026; 1,003 on June 2, 2027; 835 on June 3, 2027; 680 on June 4, 2027; 1,003 on June 2, 2028; 835 on June 5, 2028 and 1,003 on June 4, 2029. 591 shares were withheld from the 2,028 restricted shares that vested on June 2, 2026. These 591 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. This option becomes exercisable as follows: 2,623 on June 2, 2027, 2,623 on June 2, 2028, 2,623 on June 4, 2029 and 2,623 on June 3, 2030.
Shares withheld for taxes 591 shares at $209.76 Withheld from 2,028 restricted shares vested on June 2, 2026
Share grant 3,009 ordinary shares Awarded to Mary Clare Fraser on June 2, 2026 at $0.00
Options granted 10,492 options at $230.74/share Employee stock options expiring June 2, 2036
Shares owned after transactions 15,218 ordinary shares Direct ownership following June 2, 2026 transactions
Restricted shares outstanding 7,554 restricted shares Restricted as of June 2, 2026, with lapses through June 4, 2029
Vested restricted shares 2,028 restricted shares Vested on June 2, 2026; 591 withheld for taxes
Option vesting tranches 4 tranches of 2,623 options Exercisable in 2027, 2028, 2029 and 2030
restricted shares financial
"As of June 2, 2026, 7,554 of these ordinary shares are restricted."
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Employee Stock Option (right to buy) financial
"security_title: "Employee Stock Option (right to buy)""
taxes required to be withheld financial
"represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws"
NYSE closing market price financial
"These vested shares were valued at the NYSE closing market price on June 2, 2026."
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fraser Mary Clare
(Last)(First)(Middle)
70 SIR JOHN ROGERSON'S QUAY
(Street)
DUBLIN 2D02 R296
(City)(State)(Zip)
IRELAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP & Chief HRO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares06/02/2026A3,009A$015,218(1)D
Ordinary Shares06/02/2026F591(2)D$209.7614,627(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$230.7406/02/2026A10,492 (3)06/02/2036Ordinary Shares10,492$010,492D
Explanation of Responses:
1. As of June 2, 2026, 7,554 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 835 on June 3, 2026; 1,360 on June 4, 2026; 1,003 on June 2, 2027; 835 on June 3, 2027; 680 on June 4, 2027; 1,003 on June 2, 2028; 835 on June 5, 2028 and 1,003 on June 4, 2029.
2. 591 shares were withheld from the 2,028 restricted shares that vested on June 2, 2026. These 591 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.
3. This option becomes exercisable as follows: 2,623 on June 2, 2027, 2,623 on June 2, 2028, 2,623 on June 4, 2029 and 2,623 on June 3, 2030.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did STERIS (STE) executive Mary Clare Fraser report in this Form 4?

Mary Clare Fraser reported routine equity compensation and tax withholding. She received 3,009 ordinary shares and 10,492 stock options, while 591 vested shares were withheld to cover taxes, updating her direct ownership and restricted share balances.

How many STERIS (STE) shares does Mary Clare Fraser hold after these transactions?

After the transactions, Fraser holds 15,218 ordinary shares directly. Footnotes indicate 7,554 of these shares are restricted as of June 2, 2026, with those restrictions scheduled to lapse in several tranches through June 4, 2029.

What stock option grant did Mary Clare Fraser receive from STERIS (STE)?

Fraser received 10,492 employee stock options. These options allow her to buy STERIS ordinary shares at an exercise price of $230.74 per share and expire on June 2, 2036, with vesting in four equal installments from 2027 through 2030.

Why were 591 STERIS (STE) shares disposed of in Mary Clare Fraser’s Form 4?

The 591-share disposition reflects tax withholding, not a market sale. Those shares were withheld from 2,028 restricted shares that vested on June 2, 2026, to satisfy employment or tax law obligations, valued at the NYSE closing price of $209.76 per share.

How many of Mary Clare Fraser’s STERIS (STE) shares remain restricted and when do they vest?

As of June 2, 2026, 7,554 of her ordinary shares remain restricted. The restrictions lapse in scheduled tranches between June 3, 2026 and June 4, 2029, as specified for multiple vesting dates across those years.

Is Mary Clare Fraser’s Form 4 for STERIS (STE) a discretionary stock sale?

The filing primarily shows grants and tax withholding, not open-market selling. The disposition code F represents 591 shares withheld to cover taxes on vesting, while other entries are grant or award acquisitions of shares and stock options.